한빛사 논문
Tae-Eun Park1,6,9, Nur Mustafaoglu1,9, Anna Herland1,7,8, Ryan Hasselkus1, Robert Mannix1,5, Edward A. FitzGerald1, Rachelle Prantil-Baun1, Alexander Watters1, Olivier Henry1, Maximilian Benz1, Henry Sanchez1, Heather J. McCrea2, Liliana Christova Goumnerova2, Hannah W. Song3, Sean P. Palecek3, Eric Shusta3 & Donald E. Ingber1,4,5,*
1 Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02115, USA. 2 Department of Neurosurgery, Boston Children’s Hospital and Harvard Medical School, Boston, MA 02115, USA. 3 Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA. 4 Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA. 5 Vascular Biology Program and Department of Surgery, Boston Children’s Hospital and Harvard Medical School, Boston, MA 02115, USA. 6Present address: Ulsan National Institute of Science and Technology (UNIST), UNIST-gil 50, Ulsan 44919, Republic of Korea. 7Present address: Division of Micro and Nanosystems, KTH Royal Institute of Technology, Stockholm, Sweden. 8 Present address: Swedish Medical Nanoscience Center, Department of Neuroscience, Karolinska Institute, Stockholm, Sweden. 9 These authors contributed equally: Tae-Eun Park, Nur Mustafaoglu.
*Correspondence and requests for materials should be addressed to D.E.I.
Abstract
The high selectivity of the human blood-brain barrier (BBB) restricts delivery of many pharmaceuticals and therapeutic antibodies to the central nervous system. Here, we describe an in vitro microfluidic organ-on-a-chip BBB model lined by induced pluripotent stem cell-derived human brain microvascular endothelium interfaced with primary human brain astrocytes and pericytes that recapitulates the high level of barrier function of the in vivo human BBB for at least one week in culture. The endothelium expresses high levels of tight junction proteins and functional efflux pumps, and it displays selective transcytosis of peptides and antibodies previously observed in vivo. Increased barrier functionality was accomplished using a developmentally-inspired induction protocol that includes a period of differentiation under hypoxic conditions. This enhanced BBB Chip may therefore represent a new in vitro tool for development and validation of delivery systems that transport drugs and therapeutic antibodies across the human BBB.
논문정보
관련 링크
연구자 키워드
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기